Top

28-02-2024 | Athlete's Foot | Review

Tinea Pedis in Adolescents: A Comprehensive Review

Authors: Jose Ramón García-Lira, Mirna Eréndira Toledo-Bahena, Adriana María Valencia-Herrera, Rodrigo Ariel Pérez-Cosgaya, Elizabeth Marian Pardo-Estrada, Mario Rafael Duarte-Abdala, Alejandra Galeana-Aguilar, Carlos Alfredo Mena-Cedillos, Alexandro Bonifaz-Trujillo

Published in: Current Fungal Infection Reports

Abstract

Purpose of Review

The purpose of the review is to provide a detailed overview of athlete’s foot (tinea pedis) in adolescents, covering its causes, symptoms, diagnosis, treatment, and prevention.

Recent Findings

Research on adolescent athlete’s foot (tinea pedis) reveals its higher prevalence in developed countries during the summer due to communal environments and sports activities. Diagnosis methods include dermoscopy and molecular techniques, while treatment options range from topical to systemic antifungal agents. Preventive measures emphasize foot hygiene and adolescent awareness.

Summary

Tinea pedis, commonly known as athlete’s foot, is a dermatophytic fungal infection that predominantly affects the skin of the feet. This condition is particularly prevalent among adolescents, presenting both clinical and public health significance. In this comprehensive review, we aim to elucidate the epidemiology, risk factors, clinical manifestations, diagnostic modalities, treatment options, and preventive measures associated with tinea pedis in the adolescent population.

Khodadadi H, Zomorodian K, Nouraei H, Zareshahrabadi Z, Barzegar S, Zare MR, Pakshir K. Prevalence of superficial-cutaneous fungal infections in Shiraz, Iran: a five-year retrospective study (2015–2019). J Clin Lab Anal. 2021;35(7): e23850. https://doi.org/10.1002/jcla.23850.CrossRefPubMedPubMedCentral

Hawkins DM, Smidt AC. Superficial fungal infections in children. Pediatr Clin North Am. 2014;61(2):443–55. https://doi.org/10.1016/j.pcl.2013.12.003.CrossRefPubMed

Kelly BP. Superficial fungal infections. Pediatr Rev. 2012;33(4):e22-37. https://doi.org/10.1542/pir.33-4-e22.CrossRefPubMed

Flores JM, Castillo VB, Franco FC, Huata AB. Superficial fungal infections: clinical and epidemiological study in adolescents from marginal districts of Lima and Callao. Peru J Infect Dev Ctries. 2009;3(4):313–7. https://doi.org/10.3855/jidc.130.CrossRefPubMed

Alter SJ, McDonald MB, Schloemer J, Simon R, Trevino J. Common child and adolescent cutaneous infestations and fungal infections. Curr Probl Pediatr Adolesc Health Care. 2018;48(1):3–25. https://doi.org/10.1016/j.cppeds.2017.11.001.CrossRefPubMed

Ilkit M, Durdu M. Tinea pedis: the etiology and global epidemiology of a common fungal infection. Crit Rev Microbiol. 2015;41(3):374–88. https://doi.org/10.3109/1040841X.2013.856853.CrossRefPubMed

Kromer C, Celis D, Hipler UC, Zampeli VA, Mößner R, Lippert U. Dermatophyte infections in children compared to adults in Germany: a retrospective multicenter study in Germany. J Dtsch Dermatol Ges. 2021;19(7):993–1001. https://doi.org/10.1111/ddg.14432.CrossRefPubMed

Henshaw E, Olasode A. Prevalence of skin infections, infestations, and papular urticaria among adolescents in secondary schools in Calabar Nigeria. Ghana Med J. 2019;53(4):287–93.CrossRefPubMedPubMedCentral

Mayser P, Handrick W, Nenoff P. Sportassoziierte Dermatophytosen: Ein Überblick [Sports-associated dermatophytoses: an overview]. Hautarzt. 2016;67(9):680–8. https://doi.org/10.1007/s00105-016-3845-8.CrossRefPubMed

10.

Ashack KA, Burton KA, Johnson TR, Currie DW, Comstock RD, Dellavalle RP. Skin infections among US high school athletes: a national survey. J Am Acad Dermatol. 2016;74(4):679–84. https://doi.org/10.1016/j.jaad.2015.10.042.CrossRefPubMed

11.

Jenkins DW, Cooper K, Heigh EG. Prevalence of podiatric conditions seen in Special Olympics athletes: a comparison of USA data to an international population. Foot (Edinb). 2015;25(1):5–11. https://doi.org/10.1016/j.foot.2014.09.001.CrossRefPubMed

12.

Nowicka D, Bagłaj-Oleszczuk M, Maj J. Infectious diseases of the skin in contact sports. Adv Clin Exp Med. 2020;29(12):1491–5. https://doi.org/10.17219/acem/129022.CrossRefPubMed

13.

Olomukoro CN, Dlova NC, Sibanda W, Chateau AV, Archary M, Mosam A. Mucocutaneous diseases in the combined antiretroviral therapy era: prevalence and spectrum in HIV seropositive children and adolescents in Durban. South Africa Int J Dermatol. 2022;61(3):259–65. https://doi.org/10.1111/ijd.15735.CrossRefPubMed

14.

Ochoa S, Constantine GM, Lionakis MS. Genetic susceptibility to fungal infection in children. Curr Opin Pediatr. 2020;32(6):780–9. https://doi.org/10.1097/MOP.0000000000000948.CrossRefPubMedPubMedCentral

15.

• Leung AK, Barankin B, Lam JM, Leong KF, Hon KL. Tinea pedis: an updated review. Drugs Context. 2023;12:1–5. https://doi.org/10.7573/dic.2023-5-1. This article provides a recent update on tinea pedis.CrossRef

16.

Ely JW, Rosenfeld S, Seabury SM. Diagnosis and management of tinea infections. Am Fam Physician. 2014;90(10):702–10.PubMed

17.

Nigam PK, Saleh D. Tinea pedis. 2022. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023

18.

•• Ankad BS, Mukherjee SS, Nikam BP, Reshme AS, Sakhare PS, Mural PH. Dermoscopic characterization of dermatophytosis: a preliminary observation. Indian Dermatol Online J. 2020;11(2):202–7. https://doi.org/10.4103/idoj.IDOJ_190_19. This article reports the importance of dermoscopy in the diagnosis of dermatophytosis.CrossRefPubMedPubMedCentral

19.

Karaman BF, Topal SG, Aksungur VL, Ünal İ, İlkit M. Successive potassium hydroxide testing for improved diagnosis of tinea pedis. Cutis. 2017;100(2):110–4.PubMed

20.

21.

Diongue K, Ndiaye M, Diallo MA, Seck MC, Badiane AS, Diop A, et al. Fungal interdigital tinea pedis in Dakar (Senegal). J Mycol Med. 2016;26(4):312–6. https://doi.org/10.1016/j.mycmed.2016.04.002.CrossRefPubMed

22.

Conejo A, Martínez A, Ramirez O, Álvez F, Hernández A, Baquero F. Documento de consenso SEIP-AEPap-SEPEAP sobre la etiología, el diagnóstico y el tratamiento de las infecciones cutáneas micóticas de manejo ambulatorio. Rev Pediatr Aten Primaria. 2016;18:e149–72.

23.

Pichardo-Geisinger R, Mora DC, Newman JC, Arcury TA, Feldman SR, Quandt SA. Comorbidity of tinea pedis and onychomycosis and evaluation of risk factors in Latino immigrant poultry processing and other manual laborers. South Med J. 2014;107(6):374–9. https://doi.org/10.14423/01.SMJ.0000450705.67259.26.CrossRefPubMed

24.

Pires CA, Cruz NF, Lobato AM, Sousa PO, Carneiro FR, Mendes AM. Clinical, epidemiological, and therapeutic profile of dermatophytosis. An Bras Dermatol. 2014;89(2):259–64. https://doi.org/10.1590/abd1806-4841.20142569.CrossRefPubMedPubMedCentral

25.

Didehdar M, Shokohi T, Khansarinejad B, Ali Asghar Sefidgar S, Abastabar M, Haghani I, et al. Characterization of clinically important dermatophytes in north of Iran using PCR-RFLP on ITS region. J Mycol Med. 2016;26(4):345–350. https://doi.org/10.1016/j.mycmed.2016.06.006.

26.

•• Hui D, Xue-cheng S, Ai-e X. Evaluation of reflectance confocal microscopy in dermatophytosis. Mycoses. 2013;56(2):130–3. https://doi.org/10.1111/j.1439-0507.2012.02222.x. This article presents an evaluation of reflectance confocal microscopy in the context of dermatophytosis.CrossRefPubMed

27.

Sahoo AK, Mahajan R. Management of tinea corporis, tinea cruris, and tinea pedis: a comprehensive review. Indian Dermatol Online J. 2016;7(2):77–86. https://doi.org/10.4103/2229-5178.178099.CrossRefPubMedPubMedCentral

28.

Stein Gold LF, Parish LC, Vlahovic T, Plaum S, Kircik L, Fleischer AB Jr, et al. Efficacy and safety of naftifine HCl gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials. J Drugs Dermatol. 2013;12(8):911–8.PubMed

29.

Stein Gold LF, Vlahovic T, Verma A, Olayinka B, Fleischer AB Jr. Naftifine hydrochloride gel 2%: an effective topical treatment for moccasin-type tinea pedis. J Drugs Dermatol. 2015;14(10):1138–44.PubMed

30.

Kara Polat A, Akın Belli A, Göre Karaali M, Koku Aksu AE. The attitudes, behaviors, and opinions about non-pharmacological agents in patients with tinea pedis. Dermatol Ther. 2020;33(6): e14041. https://doi.org/10.1111/dth.14041.CrossRefPubMed

Title: Tinea Pedis in Adolescents: A Comprehensive Review
Authors: Jose Ramón García-Lira
Mirna Eréndira Toledo-Bahena
Adriana María Valencia-Herrera
Rodrigo Ariel Pérez-Cosgaya
Elizabeth Marian Pardo-Estrada
Mario Rafael Duarte-Abdala
Alejandra Galeana-Aguilar
Carlos Alfredo Mena-Cedillos
Alexandro Bonifaz-Trujillo
Publication date: 28-02-2024
Publisher: Springer US
Keywords: Athlete's Foot
Terbinafine
Published in: Current Fungal Infection Reports
Print ISSN: 1936-3761
Electronic ISSN: 1936-377X
DOI: https://doi.org/10.1007/s12281-024-00490-8

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com